V L MURTY
Overview
Explore the profile of V L MURTY including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
88
Citations
404
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Slomiany B, MURTY V, Piotrowski J, Slomiany A
Gen Pharmacol
. 1996 Jul;
27(5):761-71.
PMID: 8842677
1. Salivary mucins are well recognized as an important factor in the preservation of the health of the oral cavity. These large glycoproteins play a major role in the formation...
2.
Slomiany B, Piotrowski J, MURTY V, Slomiany A
Gen Pharmacol
. 1995 Nov;
26(7):1553-8.
PMID: 8690245
1. H. pylori infection causes the loss of mucus coat continuity and its patchy appearance. Here, we present evidence that the bacterium, through its cell wall lipopolysaccharide, disrupts the interaction...
3.
Slomiany B, Slomiany A, MURTY V, Piotrowski J
Gut
. 1995 Oct;
37(4):589-90.
PMID: 7489954
No abstract available.
4.
Piotrowski J, Majka J, Sano S, Nowak P, MURTY V, Slomiany A, et al.
Gen Pharmacol
. 1995 Jul;
26(4):749-53.
PMID: 7635250
1. The effect of an antiulcer agent, sulglycotide, on mucosal expression of EGF and PDGF receptors with chronic ulcer healing was investigated. 2. Rats with experimentally-induced gastric ulcers were treated...
5.
Piotrowski J, MURTY V, Slomiany A, Slomiany B
Biochem Mol Biol Int
. 1995 Mar;
35(3):467-72.
PMID: 7773183
H. pylori is regarded as a primary etiologic factor in gastric disease and the therapies now include a combination of antimicrobial agents with antiulcer drugs. Here, the effect of a...
6.
Piotrowski J, Majka J, Piotrowski E, MURTY V, Gabryelewicz A, Slomiany A, et al.
Biochem Mol Biol Int
. 1994 Nov;
34(5):875-81.
PMID: 7535617
The mucin isolated from gastric secretion of duodenal ulcer patients before and after therapy with a new antiulcer agent, ebrotidine, was assessed for H. pylori aggregating activity and macromolecular organization....
7.
Piotrowski J, Majka J, MURTY V, Czajkowski A, Slomiany A, Slomiany B
Gen Pharmacol
. 1994 Sep;
25(5):969-76.
PMID: 7835646
1. A receptor for mucin was isolated from the solubilized gastric epithelial cell membrane by affinity chromatography on Sepharose-bound wheat germ agglutinin. 2. The receptor protein displayed a molecular weight...
8.
Slomiany B, MURTY V, Piotrowski J, Slomiany A
Gen Pharmacol
. 1994 Sep;
25(5):833-41.
PMID: 7835626
1. Convincing evidence now exists that infection with H. pylori plays a major role in the pathogenesis of gastric disease. Having a niche bordering two major perimeters of mucosal defenses,...
9.
Slomiany B, Piotrowski E, Piotrowski J, Zirvi K, Liau Y, MURTY V, et al.
Gen Pharmacol
. 1994 Sep;
25(5):1033-7.
PMID: 7835621
1. Rat gastric mucosal cells, subjected to phospholipid labeling by incubating the cell suspension in DMEM with [3H]choline, were exposed to different concentrations (0-150 microM) of H2-receptor antagonists, ebrotidine and...
10.
Slomiany B, Piotrowski J, Czajkowski A, MURTY V, Majka J, Slomiany A
Biochem Mol Biol Int
. 1994 May;
33(2):229-34.
PMID: 7951043
The effect of intragastric administration of sulglycotide, a cytoprotective sulfated glycopeptide, on the expression of gastric mucosal epidermal growth factor receptor was investigated. The experiments were conducted with groups of...